Hyosang (Mark) Kim
Biography
Overview
Hyosang (Mark) Kim is an associate in the Technology Transactions Practice, within the Firm's Global M&A Group and Global IP Group. Mark focuses on transactional matters involving the development, acquisition, transfer, and licensing of intellectual property and information technology in a variety of sectors.
Prior to focusing on transactional work, Mark litigated complex patent and technology-related disputes with an emphasis on pharmaceuticals and healthcare.
Mark earned a Bachelor of Arts, with distinction, in Biology from the University of Virginia and received his law degree, with pro bono distinction, from Stanford Law School, where he served on the Stanford Technology Law Review.
Mark is admitted to the New York State Bar and is also admitted to practice before the United States Patent and Trademark Office.
Experience
Recent matters include representation of:
GlaxoSmithKline plc (LSE/NYSE: GSK) in its development and commercialization collaboration arrangements for EOS-448 (an anti-TIGIT monoclonal antibody) with iTeos Therapeutics (NASDAQ: ITOS).
Facebook in connection with various intellectual property, product, content, and technology transactions.
Panasonic Corp. in its US$8.5 billion acquisition of the remaining 80 percent of the capital stock interests of Blue Yonder, a leading end-to-end, digital fulfillment platform provider.
CVC Capital Partners in its acquisition, with minority co-investor Caisse de dépôt et placement du Québec (CDPQ), of a majority stake in the international agencies of BlueFocus Intelligent Communications Group Co., Ltd., a leading publicly-traded Chinese marketing services conglomerate.
FS Development Corp. II (NASDAQ: FSII), a SPAC, in its US$276.2 million business combination with Pardes Biosciences, Inc., an early stage biopharmaceutical company developing a potential direct-acting, oral antiviral drug to treat and prevent SARS-CoV-2 infections.
Falcon Capital Acquisition Corp. (NASDAQ: FCAC), a SPAC, in its US$3.9 billion business combination with Sharecare, Inc., a digital health company based in Georgia.
B. Riley Principal Merger Corp. II (NYSE: BMRG), a SPAC, in its US$550 million business combination with Eos Energy Services LLC, a leading manufacturer of zinc hybrid cathode battery energy storage systems.
Mill Rock Packaging Partners LLC and its affiliates in its acquisition of All Packaging Company, a cartons manufacturing company.
Priority Power Management, LLC, an independent energy management services and consulting firm, in its acquisition of Satori Enterprises LLC (d/b/a Satori Energy), a leading energy consulting firm based out of Chicago, Illinois serving more than 55,000 industrial, municipal and residential clients in 25 states, the District of Columbia, Canada and Mexico.
Colonnade Acquisition Corp. (NYSE: CLA), a SPAC, in its US$1.9 billion business combination with Ouster, Inc., a leading provider of high-resolution digital lidar sensors for the industrial automation, smart infrastructure, robotics, and automotive industries.
Foresee Pharmaceuticals Co., Ltd. in its license arrangements with GenScience Pharmaceuticals (a wholly-owned subsidiary of Changchun High-Tech Industry (Group) Co., Ltd. (000661.SZ)) for commercialization of Camcevi™ in China.
dMY Technology Group, Inc. II (NYSE: DMYD), a SPAC, in its US$1.68 billion business combination with UK-based Genius Sports Group.
dMY Technology Group, Inc. (NYSE: DMYT), a SPAC, in its US$1.78 billion business combination with Rush Street Interactive, LP, a US-based online casino and sports betting company.
Avon Rubber p.l.c. (LSE: AVON), a leading provider of life critical personal protection systems to military and first responder markets, in its US$130 million acquisition of Team Wendy, LLC, a leading supplier of critical protective systems including helmets and helmet liner and retention systems for military and first responders.
Sole Source Capital LLC, through its portfolio company Supply Chain Services, a premier provider of automatic identification and data capture and factory automation solutions, in its acquisition of Miles Data Technologies, a leading provider of barcode, RFID and mobility solutions.
Mill Rock Capital in the acquisition of Trojan Lithograph Corp., a full-service provider of high-end, graphic paper packaging, from Arbor Investments.
Roche Diagnostics Corp. in the sale of 100% of the issued and outstanding stock of Roche Health Solutions Inc. to CardioNet, LLC, a wholly owned subsidiary of BioTelemetry, Inc.
Lantheus Holdings, Inc. (NASDAQ: LNTH), a leader in the development, manufacture, and commercialization of innovative diagnostic imaging agents and products, in its offer to acquire Progenics Pharmaceuticals, Inc. (NASDAQ: PGNC), an oncology company developing innovative medicines and artificial intelligence to find, fight, and follow cancer, in an all-stock transaction.
Landcadia Holdings II, Inc. (NASDAQ: LCA), a blank check company, on its cash and stock acquisition of Golden Nugget Online Gaming, Inc. (GNOG), one of the nation's leading online casinos, from Landry's Fertitta LLC, part of the Landry's group of restaurant and hospitality businesses.
Itron Inc. in the sale of its subsidiaries comprising its manufacturing and sales operations in Latin America to buyers led by Instalación Profesional y Tecnologías del Centro S.A. de C.V., a Mexican company doing business as Accell in Brazil (Accell).
Morgan Stanley Infrastructure Inc. in its acquisition of Seven Seas Water Corp., AquaVenture Holdings Inc., and AquaVenture Holdings Curacao N.V., a multinational developer, owner and operator of water production and wastewater treatment plants and businesses, from AI Aqua (Luxembourg) S.a.r.l, a company owned by Advent International Corporation.
Harvest Partners in an investment in MRI Software, a leading provider of real estate management software solutions globally.
GPA Global, a portfolio company of EQT Partners AB and a leader in premium packaging, sustainable packaging, and display solutions based in China, on its acquisition of Hub Folding Box, a printing and packaging powerhouse with one of the most technologically advanced facilities in North America.
Advance Stores Company, Inc., a wholly owned subsidiary of Advance Auto Parts, Inc. (a leading automotive parts provider), in its acquisition of the DieHard brand from Transform Holdco LLC, a leading integrated retailer, in exchange for cash consideration.
Dominus Capital, L.P. in its acquisition of Surface Preparation Technologies, LLC, the country's leading provider of rumble strips and related roadway safety services.
Ichnos Sciences S.A. (formerly known as Glenmark Pharmaceuticals S.A.) in its biologic drug substance supply arrangements for ISB 830 (an antibody in development as a potential treatment for autoimmune diseases) with Samsung Biologics.
